Belinostat in Treating Patients With Myelodysplastic Syndromes
NCT00357162
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
NIH
Sponsor class
Conditions
de Novo Myelodysplastic Syndromes
Previously Treated Myelodysplastic Syndromes
Secondary Myelodysplastic Syndromes
Interventions
DRUG:
belinostat
Sponsor
National Cancer Institute (NCI)